Stocktoria
Alpha Teknova, Inc. TKNO
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2021-06-25
Chart by TradingView
5/9
Piotroski F — financial health
-1.59
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $40.5M | $37.7M | $36.7M | $41.4M | $36.9M |
| Gross profit | $13.4M | $7.2M | $10.3M | $17.5M | $17.6M |
| Operating income | -$17.0M | -$26.1M | -$35.6M | -$49.7M | -$12.0M |
| Net income | -$17.3M | -$26.7M | -$36.8M | -$47.5M | -$9.8M |
| Operating cash flow | -$8.6M | -$12.4M | -$18.8M | -$27.4M | -$9.1M |
| Free cash flow | -$9.8M | -$13.5M | -$26.7M | -$55.5M | -$28.9M |
| Total assets | $103.6M | $118.8M | $128.6M | $152.3M | $166.5M |
| Total liabilities | $34.8M | $36.4M | $38.6M | $52.4M | $23.3M |
| Shareholders' equity | $68.8M | $82.4M | $90.0M | $99.9M | $143.2M |
| Ratios | |||||
| Gross margin | 33.2% | 19.2% | 28.1% | 42.2% | 47.8% |
| Operating margin | -41.9% | -69.3% | -96.9% | -119.9% | -32.5% |
| Net margin | -42.6% | -70.9% | -100.3% | -114.6% | -26.6% |
| FCF margin | -24.2% | -35.8% | -72.9% | -134.1% | -78.5% |
| Return on assets | -16.7% | -22.5% | -28.6% | -31.2% | -5.9% |
| Return on equity | -25.1% | -32.5% | -40.9% | -47.5% | -6.8% |
| Debt / equity | 0.19× | 0.11× | 0.15× | 0.22× | 0.08× |
| Current ratio | 4.58 | 3.82 | 5.14 | 5.62 | 13.07 |
| Revenue growth | 7.4% | 2.9% | -11.4% | 12.3% | 17.9% |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.59 (distress)
- Working capital / assets 0.26
- Retained earnings / assets -1.311
- EBIT / assets -0.164
- Equity / liabilities 1.976
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001850902 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.